Publications by authors named "Lucia Gallo"

40 Publications

Successful treatment of eruptive pyogenic granuloma with propranolol.

Dermatol Ther 2021 May 24:e14998. Epub 2021 May 24.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.14998DOI Listing
May 2021

Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient.

Contact Dermatitis 2021 May 8. Epub 2021 May 8.

Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/cod.13882DOI Listing
May 2021

Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis.

J Clin Med 2021 Mar 3;10(5). Epub 2021 Mar 3.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy.

Psoriasis is an immune-mediated, chronic inflammatory disease, which mainly affects the skin, although it has systemic pathological effects. Comorbidities of psoriasis include ocular disorders, which are often nonspecific or mildly symptomatic. The aim of this study was to show the importance of ocular-disease screening in psoriatic patients using the Ocular Manifestations in Psoriasis Screening (OcMaPS) questionnaire. Patients suffering from moderate-to-severe psoriasis referring at our outpatient-clinic were consecutively enrolled. Each patient was asked to complete a screening questionnaire (OcMaPS). Patients reporting ocular symptoms were referred for an ophthalmological examination. A total of 372 patients were enrolled in the study. Ocular symptoms were detected in 39 patients (10.5%), and 37 patients were referred to ophthalmological examination which confirmed the presence of ocular manifestation in 30 patients. There were three cases (10%) of uveitis, 14 (46.6%) of dry eye and 13 (43.3%) of cataract, in progress or already treated with surgery. In the remaining seven patients, no ocular manifestations were found. Ocular manifestations in psoriatic patients are not rare. It is important to be aware of ocular symptoms in psoriatic patients, screening patients (with a consultation or OcMaPS questionnaire), which leads to earlier diagnosis and treatment.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm10051031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958956PMC
March 2021

Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period.

Arch Dermatol Res 2021 Feb 20. Epub 2021 Feb 20.

Section of Dermatology-Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131, Napoli, Italy.

No data on real-life experiences of risankizumab efficacy and safety are reported, apart from two isolated case reports. We carried out a single-centre, prospective study to assess the efficacy and safety of risankizumab. Fourteen patients were included (mean age 44.5 ± 14.2 years). Mean PASI decreased from 12.3 ± 5.2 (baseline) to 4.4 ± 2.7 at week 4 (p < 0.01), and to 2.7 ± 1.7 at week 16 (p < 0.001). A similar trend was observed for BSA. In patients previously treated with biologics (71.4%, n = 10) versus the naïve ones, mean baseline PASI was similar (12.7 ± 5.8 vs 11.3 ± 3.8). Mean BSA was higher in multifailure (23.5 ± 11.8 vs 15.5 ± 11.8). At 4 and 16 weeks, a significant improvement in PASI and BSA was observed in both groups. An improvement in NAPSI score, mean scalp, and palmo-plantar area reduction was noticed during follow-up. No AEs were reported up to week 16 and few and mild grade laboratory tests were reported. Our initial data confirm the promising results on efficacy and safety of Risankizumab, even in a more challenging and "real" population, composed of a high percentage of multi-failure psoriatic patients who have benefitted from a new class agent.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00403-021-02200-7DOI Listing
February 2021

Itraconazole-induced photodistributed erythema multiforme.

Dermatol Ther 2021 03 28;34(2):e14901. Epub 2021 Feb 28.

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.14901DOI Listing
March 2021

Mycoses in the elderly population: what a 16-year experience has taught us.

Int J Dermatol 2021 Feb 9;60(2):e60-e62. Epub 2020 Aug 9.

Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.15126DOI Listing
February 2021

Tinea pedis in a child: How reflectance confocal microscopy can help in diagnosis of dermatophytosis.

Pediatr Dermatol 2021 Mar 15;38(2):522-523. Epub 2020 Dec 15.

Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italia.

A 7-year-old girl presented with a hyperkeratotic scale on the plantar surface of her left foot. A microscopic potassium hydroxide examination was performed and negative. Reflectance confocal microscopy was performed showing fungal hyphae and an inflammatory infiltrate confirming a diagnosis of tinea pedis.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/pde.14487DOI Listing
March 2021

16-year real-life study on the prevalence of mycoses in a paediatric population.

G Ital Dermatol Venereol 2020 Nov 12. Epub 2020 Nov 12.

Section of Dermatology, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.20.06759-0DOI Listing
November 2020

Rowell Syndrome: A Diagnostic Challenge.

J Clin Aesthet Dermatol 2020 Apr 1;13(4):40-42. Epub 2020 Apr 1.

Drs. Gallo, Megna, Festa, Fabbrocini, and Ferrillo are with the Section of Dermatology in the Department of Clinical Medicine and Surgery at the University of Naples Federico II in Napoli NA, Italy.

Rowell syndrome is a rare disease characterized by a combination of lupus erythematosus (LE) and erythema multiforme (EM)-like lesions and a characteristic immunologic pattern, including speckled pattern of antinuclear antibody (ANA), positive anti-Ro/SSA or anti-La/SSB, and positive rheumatoid factor (RF). This disease was first described in 1963, and to date, about 95 cases of EM-like lesions associated with LE have been described in the literature, with the majority of cases being reported in adult female patients. Here, we describe the case of a 17-year-old male patient exhibiting both systemic LE and EM lesions together with ANA and anti-Ro/SSA positivity who was successfully treated with systemic corticosteroids and hydroxychloroquine.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605390PMC
April 2020

Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?

Australas J Dermatol 2021 May 18;62(2):e207-e211. Epub 2020 Oct 18.

Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.

Background: Autoimmune diseases share a significant part of their genetic background and tend to coexist in the same patient. Some studies have investigated the possible association between autoimmune thyroiditis and psoriasis or psoriatic arthritis (PsA), with conflicting results. This study aimed to investigate the prevalence of autoimmune thyroiditis in psoriatic patients with (PsA) or without (PsC) joint involvement.

Methods: 208 patients with psoriasis and/or PsA were recruited. These patients were divided into two groups: psoriasis patients (without PsA) (PsC group: 100 patients; mean age of 50.1 ± 11.7 years) and subjects with psoriasis and psoriatic arthritis (PsA group: 108 subjects: mean age of 39.8 ± 10.8 years). Assessment of psoriasis severity was conducted using the Psoriasis Area and Severity Index (PASI) score. The diagnosis of psoriatic arthritis was made according to CASPAR criteria. All patients had thyroid evaluation through evaluation of thyroid function, thyroperoxidase antibodies and thyroid ultrasound examination.

Results: A statistically significant difference was found between the prevalence of autoimmune thyroiditis in the PsA group than the PsC group (25.9 vs 9.0 %; P = 0.018) with higher trends to hypothyroidism in the PsA group compared to the PsC group (13.9% vs 2.0%, P = 0.0018).

Conclusions: The higher prevalence of autoimmune thyroiditis in the PsA group may be due to an immune dysfunction pathway in patients with psoriatic arthritis with a higher risk to develop other autoimmune diseases. This evidence confirms that psoriatic arthritis is an autoimmune disease with an overactive immune system that can involve multiple organs. Thyroid function evaluation should be part of the clinical and laboratory examination of patients with psoriatic arthritis.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.13484DOI Listing
May 2021

Vesiculobullous tinea manuum in a child.

G Ital Dermatol Venereol 2020 Oct 9. Epub 2020 Oct 9.

Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italia.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.20.06634-1DOI Listing
October 2020

QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study.

Int J Dermatol 2021 Mar 29;60(3):352-357. Epub 2020 Sep 29.

Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

Background: Tuberculosis (TB) screening is mandatory for psoriasis biologic treatment. However, evidences regarding TB screening results during biologic treatment are conflicting.

Objectives: The aim of this study is to evaluate the rate of QuantiFERON TB Gold test (QFT) conversion in psoriasis patients during biologics over time.

Methods: A 9-year single center retrospective study was performed in order to evaluate the rate of QFT conversion in patients affected by moderate-to-severe plaque psoriasis under available biological therapies (anti-TNF-α, IL-12/23, IL-17). For each patient, demographic data, age, gender, comorbidities, previous psoriasis therapy, as well as ongoing treatment type were registered. Five-hundred twenty-six patients (61.2% male, with a mean age of 52.6 ± 13.9 years) treated with biologics were enrolled.

Results: QFT conversion occurred in 6.5% of patients over a mean treatment duration of 3.2 years. On average, QFT conversion occurred after 34.05 months of treatment. Anti-TNF-α drugs, and among them, adalimumab above all (35.5% of all cases), were the most commonly involved treatment during QFT conversion, followed by anti-IL-12/23 (17.6%) and anti-IL-17 (14.7%). However, differences among biologics class or single biologics (adalimumab, etanercept, infliximab, golimumab, certolizumab, ustekinumab, ixekizumab, secukinumab) did not approach statistical significance.

Conclusions: Annual TB screening is important in psoriasis patients under biologic treatment in order to avoid possible latent TB infection reactivation. Indeed, our data showed that even in a low TB prevalence country like Italy, QFT may convert over time in psoriasis patients under biologics in 6.5% of the cases.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.15217DOI Listing
March 2021

Psychological teleconsultations in patients suffering from chronic skin diseases during the COVID-19 era: a service to improve patients' quality of life.

J Dermatolog Treat 2020 Oct 12:1-2. Epub 2020 Oct 12.

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.

The COVID-19 era represented an important stressful event affecting population in many different ways, with important negative impact on social, working and relational life. Indeed, the home-isolation in addition to the high-level of distress given by fear of infection, has significantly resulted in a large number of psychological-consequences. Moreover, in order to guarantee a continuity of care, different measures have been applied among hospitals such as the implementation of teledermatology services. For these reasons, we implemented at our Dermatological-Clinic psychological video-consultations through our teledermatology-services. Herein we report our experience of 23 psychological-video-consultations, which led to achieve a significant reduction of DLQI (from 4.4 ± 3.9 at baseline to 1.6 ± 2.5 at week-4) in patients suffering from chronic skin conditions during the COVID-19 era.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1080/09546634.2020.1809625DOI Listing
October 2020

Impact of current anti-psoriatic systemic treatments on male and female fertility: what the endocrinologist needs to know.

Minerva Endocrinol 2020 Jul 23. Epub 2020 Jul 23.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Fertility is a function of the body that often is overlooked as a site for the expression of the side effects of certain drugs. With the approval of new drugs with a totally innovative mechanism of action, the risk assessment on fertility both in male and female is more difficult. This is particularly true in psoriasis, an invalidating inflammatory skin disease. The estimated prevalence of psoriasis in adults ranged from 0.51% to 11.43%, and in children from 0% to 1.37%, with frequent diagnosis in young patients of childbearing age. With the increasing use of new, predominantly immunosuppressive or biologic drugs for psoriasis, questions frequently arise in clinical practice as to their safety in men and women wishing to procreate. Both psoriatic patients and their physicians are concerned about adverse effects of the disease and its treatment on their future fertility, causing additional concerns in the therapeutic management of these patients. Among anti-psoriatic drugs, conventional therapies are mainly involved in the onset of infertility in both sexes, exerting in some cases toxic effects against reproductive organs. Conversely, biologic agents appear to improve male and female fertility especially when gonadal impairment is related to inflammatory phenomena. There is a lack of review articles of commonly used medications in psoriasis with respect to their potential effects on fertility. This paper aims to provide a practical guide for both dermatologist and endocrinologist in therapeutic management of psoriatic patients of childbearing age, considering the impact of prescribed drugs on their current and future fertility.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0391-1977.20.03236-8DOI Listing
July 2020

Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome.

Int Wound J 2020 Oct 22;17(5):1528-1531. Epub 2020 May 22.

Section of Dermatology, Department of Clinical Medicine and Surgery , University of Naples Federico II, Napoli, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/iwj.13403DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948612PMC
October 2020

COVID-19 pandemic: University of Naples Federico II Dermatology's model of dermatology reorganization.

Int J Dermatol 2020 Jul 2;59(7):e239-e240. Epub 2020 May 2.

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Napoli, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/ijd.14915DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267407PMC
July 2020

Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?

J Am Acad Dermatol 2020 06 9;82(6):e227. Epub 2020 Apr 9.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2020.03.098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194822PMC
June 2020

An enigma for the head.

G Ital Dermatol Venereol 2020 Mar 10. Epub 2020 Mar 10.

Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy -

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.20.06511-6DOI Listing
March 2020

A case of severe psoriasis in a 84-year-old women successfully treated with ixekizumab.

Dermatol Ther 2020 05 18;33(3):e13299. Epub 2020 Mar 18.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.13299DOI Listing
May 2020

Grover disease in a young woman: report of case.

G Ital Dermatol Venereol 2020 Mar 4. Epub 2020 Mar 4.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.20.06529-3DOI Listing
March 2020

Eczematous reaction to ixekizumab successfully treated with dupilumab.

Dermatol Ther 2020 03 17;33(2):e13218. Epub 2020 Jan 17.

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.13218DOI Listing
March 2020

Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018).

Skin Appendage Disord 2019 Nov 23;5(6):359-361. Epub 2019 Apr 23.

Section of Dermatology, University of Naples Federico II, Naples, Italy.

Introduction: Tinea capitis is a dermatophytic infection of the scalp hair commonly affecting children in school age.

Methods: Here we report our data of a 5-year retrospective study, including all patients between 1 and 18 years old referred to our Mycological Laboratory for suspected tinea capitis.

Results: A total of 202 patients were included and positive tests for tinea capitis were found in 86/202 (42.57%) patients. Most of the patients, 126/202 (62.38%), had not applied any topical therapy or taken any systemic drug, whereas 76/202 (37.62%) had already treated the disease.

Discussion: We underline the importance of the differential diagnosis of scalp lesions, the possibility of the so-called "tinea incognita" in some cases, and the species isolated in fungal cultures. A high number of were isolated (71/86; 82%) and this phenomenon may be due to a particular suspected clinical picture of tinea capitis that induced the dermatologist to ask for a more detailed exam.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1159/000500273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883463PMC
November 2019

A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast.

Mycoses 2019 Aug 23;62(8):659-664. Epub 2019 May 23.

Department of Dermatology, University of Naples Federico II, Naples, Italy.

Because of their similar clinical presentation, discrimination between nail psoriasis and onychomycosis often is difficult. We aim to investigate the actual frequency of onychomycosis in psoriatic patients and to compare it between psoriatic and non-psoriatic patients. This retrospective study included a total of 9281 patients, referring to our Mycology Laboratory from September 2003 to May 2018. The patients are divided into two groups: PsoGroup (patients with psoriasis) and non-PsoGroup (non-psoriatic patient). Direct microscopic examination with 20% KOH and culture was carried out in both groups. In PsoGroup (711 patients, 59.50% female, 40.50% male, median age of 52.22 ± 15.01), the prevalence of onychomycosis was 49.08%. On the other hand, in non-PsoGroup (8570 patients (71.65% female, 28.35% male, median age of 48.51 ± 19.31 years), the prevalence of onychomycosis was 51.30%. There was no statistically significant difference between the prevalence of onychomycosis in PsoGroup 49.08% (349/711) compared to 51.30% (4397/8570) of non-PsoGroup (P = 0.2578). However, yeasts were significantly more prevalent in non-psoriatic than in psoriatic patients (P = 0.0144.). In our Mycological Laboratory, we observed a similar prevalence of onychomycosis in psoriatic patients and non-psoriatic patients. However, the spectrum of fungal species isolated was different from each other, with a higher prevalence of yeasts in non-PsoGroup that reflect a recent oriental trends.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12925DOI Listing
August 2019

An Undetected Case of Tinea Capitis in an Elderly Woman Affected by Dermatomyositis: How Trichoscopy Can Guide to the Right Diagnosis.

Skin Appendage Disord 2019 Apr 24;5(3):186-188. Epub 2019 Jan 24.

Dermatology Division, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Dermatomyositis (DM) is an autoimmune disease that primarily affects the skin and muscles, but may also have a systemic involvement. The frequency of scalp involvement in DM varies from 28 to 82% and is often encountered as part of a DM flare. However, it frequently presents as a treatment-resistant disease, and patients reporting no improvement with conventional therapies require further investigation. We report a case of tinea capitis (TC) in a 79-year-old woman affected by DM with scalp involvement which did not respond to conventional therapies. Thanks to trichoscopy we could detect "comma hairs," "zigzag hairs," and "pigtail hairs" at scalp examination, made the right diagnosis of TC, and instituted the best treatment without delay.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1159/000495805DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489035PMC
April 2019

Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.

J Cutan Pathol 2019 Aug 10;46(8):619-622. Epub 2019 May 10.

Department of Advanced Biomedical Sciences, Pathology Section, University of Naples Federico II, Naples, Italy.

Plasmablastic multiple myeloma is an uncommon morphological variant of multiple myeloma with aggressive clinical course and poor outcome. Its differential diagnosis includes plasmablastic lymphoma, a variant of diffuse large B-cell lymphoma with frequent extranodal presentation, which usually affects immunosuppressed patients and is virtually indistinguishable from plasmablastic multiple myeloma on the basis of histology solely. Differential diagnosis relies on close clinical-pathological correlation. Herein, the authors report a case of aggressive multiple myeloma occurring in a 48-year-old patient with pure plasmablastic morphology, expression of T-cell markers CD3 and CD4, and cutaneous involvement as first presenting sign. Heterotopic expression of T-cell markers has been described in literature for both plasmablastic multiple myeloma and plasmablastic lymphoma. The causative mechanisms underlying this aberrant phenotype have not yet been elucidated; nevertheless the possibility of this rare finding should be considered to avoid misinterpretations. Remarkably, despite occurring rarely, cutaneous involvement could be observed at an early stage or even be the first manifestation of disease in particularly aggressive forms of myeloma. As a consequence, the presence of cutaneous lesions should not favor a straightforward diagnosis of plasmablastic lymphoma. The importance of a correct differential diagnosis lies in its therapeutical implications.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.13486DOI Listing
August 2019

Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis.

Dermatol Ther 2019 05 21;32(3):e12900. Epub 2019 Apr 21.

Department of Health Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy.

The pathogenic mechanism of hypersensitivity reactions (HSRs) to monoclonal antibodies is not fully understood. HSRs can occur after the first exposure or multiple exposures and include acute infusion reactions induced by cytokine release, besides Type I, Type III, and Type IV reactions.). We reported a case of anaphylactic reaction to certolizumab pegol in a patient affected by psoriatic arthritis and a possible management of this condition.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.12900DOI Listing
May 2019

It Is Not as It Seems.

Skin Appendage Disord 2019 Feb 21;5(2):124-126. Epub 2018 Aug 21.

Section of Dermatology, Department of Clinical Medicine and Surgery, Dermatology Unit, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1159/000492036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388554PMC
February 2019

A case of erythrodermic psoriasis successfully treated with ixekizumab.

Dermatol Ther 2019 03 31;32(2):e12825. Epub 2019 Jan 31.

Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

Erythrodermic psoriasis (EP) is the most severe form of psoriasis, resulting in significant morbidity and mortality. International guidelines on EP treatment are lacking, with most of the biologic drugs being used basing on case reports or small case series. Ixekizumab, a fully human anti-interleukin (IL)-17A monoclonal antibody, is approved for moderate to severe plaque psoriasis while its use in EP is off label. However, two studies conducted on eight Japanese EP patients have showed ixekizumab as an efficacious and well tolerated therapy up to 24 and 52 weeks, respectively. To date, no case reports on Caucasian patients have been described. We report the case of a 66-year-old Caucasian female with EP successfully treated with ixekizumab, reaching PASI 100 after only 6 weeks of therapy and still maintaining this response at week 24. Our case report suggests ixekizumab as a highly efficacious treatment in EP, presenting also a very rapid action which leads to complete resolution of the disease after 6 weeks. Further studies are warrant to confirm our data, with controlled trials specifically dedicated to EP being strictly needed in order to verify the role and efficacy of the new biologics in EP.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.12825DOI Listing
March 2019

Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal region: report of two cases.

G Ital Dermatol Venereol 2019 Jan 15. Epub 2019 Jan 15.

Section of Dermatology, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0392-0488.18.06208-9DOI Listing
January 2019

Trügerische Vesikel.

J Dtsch Dermatol Ges 2018 Dec;16(12):1499-1501

Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/ddg.13686_gDOI Listing
December 2018
-->